中国病理生理杂志
中國病理生理雜誌
중국병리생리잡지
CHINESE JOURNAL OF PATHOPHYSIOLOGY
2006年
2期
247-250
,共4页
陈琼玉%孙奋勇%陈小佳%谢秋玲%孙晋华%洪岸
陳瓊玉%孫奮勇%陳小佳%謝鞦玲%孫晉華%洪岸
진경옥%손강용%진소가%사추령%손진화%홍안
成纤维细胞生长因子2%结构类似物%大肠杆菌
成纖維細胞生長因子2%結構類似物%大腸桿菌
성섬유세포생장인자2%결구유사물%대장간균
Fibroblast growth factor 2%Construction analog%Escherichia coli
目的:用基因工程的方法获得高效稳定表达的重组人碱性成纤维细胞生长因子结构类似物.方法:利用定点突变技术,将天然hbFGF的第78与96位半胱氨酸替换为丝氨酸,通过载体pET-3c,突变基因被克隆并转化至大肠杆菌BL21(DE3)plysS,IPTG诱导表达后,SDS-PAGE分析蛋白表达结果.结果:纯化后突变蛋白的可溶性成分大幅度增加,而二聚体与多聚体显著减少至纯化后总蛋白的8%以下.MTT法的结果表明,结构类似物蛋白具有良好的生物学活性.这种新的结构类似物蛋白能较好地替代天然hbFGF在临床上的使用.结论:在不影响生物学活性的条件下,对个别氨基酸残基进行突变以获得新的结构类似物的方法,能够有效提高外源蛋白在大肠杆菌中表达的稳定性及可溶性.
目的:用基因工程的方法穫得高效穩定錶達的重組人堿性成纖維細胞生長因子結構類似物.方法:利用定點突變技術,將天然hbFGF的第78與96位半胱氨痠替換為絲氨痠,通過載體pET-3c,突變基因被剋隆併轉化至大腸桿菌BL21(DE3)plysS,IPTG誘導錶達後,SDS-PAGE分析蛋白錶達結果.結果:純化後突變蛋白的可溶性成分大幅度增加,而二聚體與多聚體顯著減少至純化後總蛋白的8%以下.MTT法的結果錶明,結構類似物蛋白具有良好的生物學活性.這種新的結構類似物蛋白能較好地替代天然hbFGF在臨床上的使用.結論:在不影響生物學活性的條件下,對箇彆氨基痠殘基進行突變以穫得新的結構類似物的方法,能夠有效提高外源蛋白在大腸桿菌中錶達的穩定性及可溶性.
목적:용기인공정적방법획득고효은정표체적중조인감성성섬유세포생장인자결구유사물.방법:이용정점돌변기술,장천연hbFGF적제78여96위반광안산체환위사안산,통과재체pET-3c,돌변기인피극륭병전화지대장간균BL21(DE3)plysS,IPTG유도표체후,SDS-PAGE분석단백표체결과.결과:순화후돌변단백적가용성성분대폭도증가,이이취체여다취체현저감소지순화후총단백적8%이하.MTT법적결과표명,결구유사물단백구유량호적생물학활성.저충신적결구유사물단백능교호지체대천연hbFGF재림상상적사용.결론:재불영향생물학활성적조건하,대개별안기산잔기진행돌변이획득신적결구유사물적방법,능구유효제고외원단백재대장간균중표체적은정성급가용성.
AIM: To obtain a high and stable expression analog of human basic fibroblast growth factor by genetic engineering. METHODS: The cysteins 78 and 96 of natural hbFGF polypeptide was substituted with serines by means of site-directed mutagenesis. Using pET- 3c as vector, the mutated polynucleotide was cloned and then transferred into BL21 (DE3)plysS. After induction by IPTG, the analog was obtained and analyzed by SDS - PAGE. RESULTS: After purification the form of soluble mutant increased remarkably but the forms of dimmer and higher multimer were reduced greatly to no more than 8% of the total recombinant protein. By MTT assay, the analog showed the same biological activity. This new analog represented a desirable complementation for native hbFGF to develop pharmaceutical drug in clinical use. CONCLUSION: Substitution of certain amino acids of polypeptide without altering native protein' s bioactivity to get the analog is an effective means to increase stability of foreign protein and its solubility in E. coli.